Abstract
Low levels of high density lipoprotein (HDL) cholesterol have been associated with an increased risk of coronary heart disease. In this chapter, we discuss the compositional and functional heterogeneity of HDL particles. We briefly describe different approaches to HDL particle characterization (by size, by apolipoprotein content, by protein content) and concentrate specifically on characterization by two-dimensional gel electrophoresis, immunoblotting, and image analysis. We describe the presence of distinct apolipoprotein A-I containing HDL particles and their major apolipoprotein compositions. These particles include very small, discoidal preβ-1 precursor HDL, very small discoidal α-4 HDL, small semi-spherical α-3 HDL, medium spherical α-2 HDL, and large spherical α-1 HDL. In addition, we review recent findings related to HDL proteomics and to possible new functions of HDL. In addition to reverse cholesterol transport, HDL has a large variety of other functions, as evidenced by the discovery of a large number of complement proteins, proteases, coagulation proteins, and proteins associated with HDL and involved in angiogenesis, cell adhesion, oxidation, and hemoglobin metabolism. These observations suggest an important role for HDL particles in the immune response, proteolysis, coagulation, angiogenesis, and other processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barklay M, Barklay RK, Skipski VP (1963) High-density lipoprotein concentrations in men and women. Nature 200:362–363
Fredrickson DS (1964) The inheritance of high density lipoprotein deficiency (Tangier Disease). J Clin Invest 43:228–236
Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R (2003) Effect of recombinant apoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290(17):2292–2300
Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC (1987) Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 68(1–2):35–40
Kostner G, Alaupovic P (1972) Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry 11(18):3419–3428
Castro GR, Fielding CJ (1988) Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 27(1):25–29
Asztalos BF, Sloop CH, Wong L, Roheim PS (1993) Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim Biophys Acta 1169(3):291–300
Asztalos BF, Schaefer EJ, Horvath KV, Yamashita S, Miller M, Franceschini G, Calabresi L (2007) Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 48(3):592–599
Phillips JC, Wriggers W, Li Z, Jonas A, Schulten K (1997) Predicting the structure of apolipoprotein A-1 in reconstituted high-density lipoprotein disks. Biophys J 73:2337–2346
Segrest JP, Jones MK, Klon AE, Sheldahl CJ, Hellinger M, De Loof HM, Harvey SC (1999) A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol Chem 274(45):31755–31758
Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH (2005) Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res 46(10):2246–2253
Cheung MC, Brown BG, Wolf AC, Albers JJ (1991) Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32(3):383–394
de Beer MC, Webb NR, Whitaker NL, Wroblewski JM, Jahangiri A, van der Westhuyzen DR, de Beer FC (2009) SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL. Arterioscler Thromb Vasc Biol 29(9):1298–1303
Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, Webb NR, van der Westhuyzen DR, de Beer FC (2009) HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol 29(2):261–267
Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hama S, Reddy ST, Fogelman AM (2007) Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. J Lipid Res 48(11):2344–2353
van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC (2005) Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 280(43):35890–35895
Guerin M, Lassel TS, Le Goff W, Farnier M, Chapman MJ (2000) Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler Thromb Vasc Biol 20(1):189–197
Santos RD, Schaefer EJ, Asztalos BF, Polisecki E, Wang J, Hegele RA, Martinez LR, Miname MH, Rochitte CE, Da Luz PL, Maranhão RC (2008) Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency. J Lipid Res 49(2):349–357
Asztalos BF, Brousseau ME, McNamara JR, Horvath KV, Roheim PS, Schaefer EJ (2001) Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 156(1):217–225
Asztalos BF, Horvath KV, Kajinami K, Nartsupha C, Cox CE, Batista M, Schaefer EJ, Inazu A, Mabuchi H (2004) Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency. J Lipid Res 45(3):448–455
Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117(3):746–756
Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A (2009) Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol 29(6):870–876
Asztalos BF, Roheim PS, Milani RL, Lefevre M, McNamara JR, Horvath KV, Schaefer EJ (2000) Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20(12):2670–2676
Zhang W, Asztalos B, Roheim PS, Wong L (1998) Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I. J Lipid Res 39(8):1601–1607
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Asztalos, B.F. (2010). High Density Lipoprotein Particles. In: Schaefer, E. (eds) High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1059-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1059-2_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1058-5
Online ISBN: 978-1-4419-1059-2
eBook Packages: MedicineMedicine (R0)